VERRICO, MONICA
 Distribuzione geografica
Continente #
NA - Nord America 1.257
EU - Europa 751
AS - Asia 271
AF - Africa 11
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.302
Nazione #
US - Stati Uniti d'America 1.244
IT - Italia 365
SE - Svezia 138
SG - Singapore 95
IN - India 93
CN - Cina 60
FI - Finlandia 45
DE - Germania 36
IE - Irlanda 33
FR - Francia 28
UA - Ucraina 25
BE - Belgio 19
GB - Regno Unito 18
ID - Indonesia 16
RO - Romania 13
BG - Bulgaria 11
CA - Canada 10
TG - Togo 8
AR - Argentina 6
AL - Albania 3
BR - Brasile 3
NL - Olanda 3
RU - Federazione Russa 3
ZA - Sudafrica 3
CL - Cile 2
ES - Italia 2
MX - Messico 2
PL - Polonia 2
PT - Portogallo 2
TW - Taiwan 2
AT - Austria 1
CH - Svizzera 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EU - Europa 1
IR - Iran 1
JP - Giappone 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
TM - Turkmenistan 1
Totale 2.302
Città #
Fairfield 152
Chandler 140
Ashburn 134
Rome 127
Woodbridge 73
Singapore 64
Houston 61
Seattle 54
Cambridge 53
Wilmington 52
Ann Arbor 41
Beijing 40
Princeton 40
Dublin 31
San Paolo di Civitate 31
Plano 30
Lawrence 21
Boston 19
Millbury 19
Milan 18
Brussels 17
Jakarta 16
New York 16
Pune 15
San Diego 14
Boardman 12
Florence 11
Helsinki 11
Sofia 11
Norwalk 10
Bremen 9
Dallas 9
Andover 8
Jacksonville 8
Lomé 8
Cappelle sul Tavo 7
Southend 7
Dearborn 6
Federal 6
Paris 6
Fremont 5
Ottawa 5
Santa Clara 5
Toronto 5
Villasanta 5
Des Moines 4
Genoa 4
Grafing 4
London 4
Turin 4
Washington 4
Albenga 3
Bologna 3
Castel d'Ario 3
Frankfurt am Main 3
Lappeenranta 3
Moscow 3
Mountain View 3
Mumbai 3
Munich 3
Padova 3
Palermo 3
Phoenix 3
Redwood City 3
Savona 3
Vicenza 3
Ancona 2
Bagheria 2
Bari 2
Bühl 2
Castellanza 2
Castelnuovo Magra 2
Falkenstein 2
Falls Church 2
Fano 2
Faro 2
Ferrara 2
Giovinazzo 2
Grumo Nevano 2
Hefei 2
Hyderabad 2
Imola 2
Jinan 2
Jinhua 2
Kunming 2
Laurel 2
Livorno 2
Liège 2
Lucca 2
Mexico City 2
Naro 2
Pomezia 2
Romainville 2
San Mateo 2
Silverton 2
Sinalunga 2
Stockholm 2
Tacoma 2
Taipei 2
Taranto 2
Totale 1.569
Nome #
Angiogenic factors as prognostic markers in neuroendocrine neoplasms 168
Breast metastasis and lung large-cell neuroendocrine carcinoma: first clinical observation 117
Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC) 117
Capecitabine and Temozolomide (CAPTEM) in advanced neuroendocrine neoplasms (NENs): a systematic review and pooled analysis 103
Efficacy and safety analysis of once per cycle pegfilgrastim and daily lenograstim in patients with breast cancer receiving adjuvant myelosuppressive chemotherapy FEC 100: a pilot study. 85
The role of BMI and age in chemotherapy-induced amenorrhea (CIA) in premenopausal breast cancer (PBC) patients treated with adjuvant FEC100 with or without docetaxel (D) 80
Oral contraceptives and clinical recurrence of human papillomavirus lesions and cervical intraepithelial neoplasia following treatment 70
Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis 68
Laser vaporization in the management of CIN 65
Conservative approach to preneoplastic cervical lesions in postmenopause 59
Single-center experience with pegfilgrastim (P) and lenograstim (L) in nonmetastatic breast cancer (NMBC) patients (pts) during adjuvant FEC100 or sequential FEC100 plus DOCETAXEL100 (D100) 58
Expression of er, pgr, her-2, and ki-67 in core biopsies and in definitive histological specimens in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy 58
Natural History and Management of Familial Paraganglioma Syndrome Type 1: Long-Term Data from a Large Family 55
An unusual case of spleen metastasis from carcinoma ex pleomorphic adenoma of the parotid gland 53
Nonpegylated liposomal doxorubicin (nPLD) in neoadjuvant treatment of local advanced breast cancer (LABC) patients (pts) 53
BODY MASS INDEX (BMI) AND AMENORRHEA IN PREMENOPAUSAL BREAST CANCER PATIENTS (PBC) TREATED WITH ADJUVANT ANTRACYCLINE AND CYCLOPHOSPAMIDE CHEMOTHERAPY (CT) 51
Cell-free circulating tumor DNA(ctDNA) analysis by next generation sequencing(NGS) panel in non small cell lung cancer patients(NSCLC): implications in clinical practice. XX Congresso Nazionale AIOM 2018 (Poster D18) 51
Metachronous and synchronous cancers in patients with neuroendocrine tumors 50
null 48
EFFICACY AND SAFETY PROFILES OF PEGFILGRASTIM (P) AND LENOGRASTIM (L) IN NON METASTATIC BREAST CANCER (NMBC) PATIENTS RECEIVING ADJUVANT FEC100 47
Neuroendocrine carcinomas with atypical proliferation index and clinical behavior: a systematic review 47
NETest: a systematic review focusing on the prognostic and predictive role 46
null 45
Cervical intraepithelial neoplasia: Risk factors for persistence and recurrence in adolescents 44
Clinical management and follow-up of squamous intraepithelial cervical lesions during pregnancy and postpartum 44
Neoplasie utero - Carcinoma della cervice uterina - Carcinoma dell’endometrio 44
Prognostic significance of laterality in lung neuroendocrine tumors 40
Correlation between squamous intraepithelial lesions (SILs) and bacterial vaginosis 39
Angioside: the role of angiogenesis and hypoxia in lung neuroendocrine tumours according to primary tumour location in left or right parenchyma 37
Correlation between bmi and chemotherapy related amenorrhea (cra) in premenopausal breast cancer patients (pbcp) 37
Fertility and reproduction in breast cancer patients 36
Capecitabine in treating patients with advanced, persistent, or recurrent cervical cancer: an active and safe option? 36
The strange case of a pancreatic neuroendocrine carcinoma with low proliferation index and atypical clinical behavior 35
null 33
Correlation between BMI and chemotherapy related amenorrhea (CRA) in premenopausal breast cancer (PBC) patients treated with adjuvant anthracycline-cyclophosphamide (AC) and docetaxel (T) 31
L78 ROLE OF PEGFILGASTIM (P) AND LENOGASTIM (L) IN PATIENTS WITH NON-METASTATIC BREAST CANCER RECEIVING ADJUVANT FEC 100 CHEMOTHERAPY 30
Lenograstim (l) versus pegfilgrastim (p) in management of chemotherapy related neutropenia (crn) in non metastatic breast cancer patients (nmbcp) 29
null 29
Incidence of amenorrhea in premenopausal women with breast cancer (BC) undergoing chemotherapy (CT) with antracyclines (A), cyclophosfamide (C) and docetaxel (D) 29
Platelet-derived circRNAs signature in patients with gastroenteropancreatic neuroendocrine tumors 26
Surgical and survival outcomes with perioperative or neoadjuvant immune-checkpoint inhibitors combined with platinum-based chemotherapy in resectable NSCLC: A systematic review and meta-analysis of randomised clinical trials 25
Sarcopenia in Breast Cancer Patients: A Systematic Review and Meta-Analysis 25
INCIDENCE OF ANTRACYCLINE CARDIOTOXICITY IN BREAST CANCER WOMEN: A RETROSPECTIVE ANALYSIS OF 6 YEARS CLINICAL PRACTICE 25
L70 MANAGEMENT OF NEUTROPENIA: EFFICACY AND SAFETY OF LENOGASTIM (L) AND PEGFILGASTIM (P) IN NON-METASTATIC BREAST CANCER PATIENTS TREATED WITH FEC 100 PLUS DOCETAX 22
Immunotherapy for Aggressive and Metastatic Pituitary Neuroendocrine Tumors (PitNETs): State-of-the Art 21
Incidence of chemotherapy (CT) induced amenorrhea in premenopausal patients (pts) with breast cancer (BC) following adjuvant anthracycline (A), cyclophosphamide (C), and taxane (T) 21
Primary prophylaxis of neutropenia in women affected by breast cancer undergoing adjuvant chemotherapy with fec 100+/- docetaxel. Comparison of efficacy and tolerability between lenograstim and pegfilgrastim 21
null 20
Thyroid transcription factor-1 expression in lung neuroendocrine tumours: a gender-related biomarker? 19
Bevacizumab in ovarian cancer: A critical review of phase III studies 19
Efficacy, safety and cost-effectiveness (ce) analysis of lenograstim (l) versus pegfilgrastim (p) in management of chemotherapy related neutropenia (crn) in non metastatic breast cancer (bc) patients 18
The role of body mass index (bmi) on chemotherapy related amenorrhea (cra) in premenopausal breast cancer (bc) patients treated with adjuvant anthracycline , cyclophosphamide (ac) and taxane (t) 17
Predictive Factors of Response to Streptozotocin in Neuroendocrine Pancreatic Neoplasms 8
New Prognostic Frontiers for Lung Neuroendocrine Tumors 7
Totale 2.461
Categoria #
all - tutte 8.272
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.272


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020292 0 0 0 17 29 30 45 36 53 37 27 18
2020/2021160 23 21 14 13 2 11 1 13 19 20 5 18
2021/2022438 1 11 29 31 54 15 12 51 48 25 86 75
2022/2023601 101 125 41 40 62 56 24 35 77 9 25 6
2023/2024456 22 45 25 39 52 111 15 37 9 33 34 34
2024/2025186 21 42 84 39 0 0 0 0 0 0 0 0
Totale 2.461